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Available online 14 July 2008The systematic review by Sigitas Urbonavicius et al.
addresses an important but poorly covered area of vascular
research. The identification of biomarkers for AAA would
be an important step towards simplifying diagnostic testing,
determination of rupture risk, enhancing post-operative fol-
low-up in patients following endovascular repair, and, most
importantly, identifying the pathophysiological processes
underlying aneurysm genesis and subsequent expansion.
Urbonavicius et al. provides comprehensive documenta-
tion of the previous research in this area to date. When
examining the data presented it is clear that none of the
potential biomarkers reviewed could be used as a diagnostic
test for AAA. Some of the papers reviewed give the results
of analyses of their biomarkers as diagnostic tests and
where these are given they demonstrate the deficiency of
the studied biomarker in this area. Often the most informa-
tive method for comparing the utility of a biomarker is the
area under the receiver-operator characteristic curve and
these figures are notably absent in the literature on AAA
(and to our knowledge have only been quoted once).1* Corresponding author. Tel.: þ44 116 252 3252; fax: þ44 116 252
3140.
E-mail address: rs152@le.ac.uk (R.D. Sayers).
1078-5884/$34 ª 2008 European Society for Vascular Surgery. Publishe
doi:10.1016/j.ejvs.2008.06.007Traditionally the hypothesis based research approach
adopted by the authors of the studies examined in this
review has been considered to be the most valid method for
studying disease. Arguably, this ‘hypothesis based’ approach
has usually been adopted for reasons of simplicity e until
recently it has not been possible to perform studies examin-
ing multiple biomarkers at once. However, with recent
technological advances it is now possible to examine the
entire proteomeor selected sub-sections of it at once inmore
descriptive proteomics experiments. Whilst descriptive re-
search has often been dismissed in the past,2 in areas such as
biomarkers for AAA where, as shown in this review, hypothe-
sis based approaches have largely failed, descriptive proteo-
mic approaches are an attractive alternative.
Proteomics is the large scale study of proteins. There are
multiple different experimental strategies that can be
adopted to perform proteomic analyses. Two-dimensional
gel electrophoresis3 has traditionally been used but is slowly
becoming superseded by mass-spectroscopic profiling.
Through laser desorbtion-ionisation time-of flight mass spec-
troscopic techniques mass/charge spectra of almost entire
proteomes can be determined very quickly. By comparing
the spectroscopic profiles seen in those with disease to
healthy controls a disease profile can beconstructed. Often
these profiles will utilise multiple mass/charge peaks and
can result in impressive diagnostic statistics for a particulard by Elsevier Ltd. All rights reserved.
282 M.J. Bown, R.D. Sayersset of biomarker peaks with areas under ROC curves
approaching 1.4,5 The disadvantage of mass-spectroscopic
techniques is the inability to determine the identity of
a mass/charge peak directly. Because of this whilst
biomarkers based on mass-spectra are relatively straightfor-
ward to identify they are therefore of limited clinical utility.
Tandem mass-spectroscopy has the potential to directly
determine both initial spectra and identify the protein
underlying the spectroscopic mass/charge peak6 but there
are very few successful reports of biomarkers identified
using this technique. Other technologies that may facilitate
the search for AAA biomarkers are difference gel
electrophoresis.7
An important consideration in the conduct of large-scale
descriptive research studies is data analysis. The field of
bioinformatics has rapidly expanded in line with recent
biotechnological advances. Bioinformatics is the applica-
tion of computer technology to biological information and
permits the application of complex, often iterative analy-
ses to the large amounts of data produced by proteomic
techniques. It may also facilitate the analysis of hypothesis
based experiments by permitting the analysis of biomarker
panels through not only standard multi-variate statistical
approaches but alternative methods such as dimension
reduction techniques8 and genetic algorithms.9 If proteo-
mic approaches are to be used in the future the need for
bioinformatic support must be considered.
In the future it is likely that research in this area will
adopt dual approaches of descriptive proteomics studies
and hypothesis based approaches. In the near future several
genome-wide association studies of AAA are to be
completed and the results of these are likely to generate
new areas of research and the gene-products associated
with the genetic variants associated with AAA are candidatebiomarkers to be tested. The generation of proteomic
profiles of AAA at different stages of development has the
potential to determine whether there are different
pathological processes occurring in small and large AAA.
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